Education
About Us
Working with TipRanks
Follow Us
Artemis Medicare Services Ltd. (IN:ARTEMISMED)
:ARTEMISMED
ARTEMISMED Stock Chart & Stats
₹276.20
₹1.60(0.48%)
At close: 4:00 PM EST
₹276.20
₹1.60(0.48%)
Day’s Range― - ―
52-Week Range₹208.75 - ₹305.95
Previous CloseN/A
Volume93.41K
Average Volume (3M)16.54K
Market Cap
₹37.68B
Enterprise Value₹36.79B
Total Cash (Recent Filing)₹3.95B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)34.2
Beta1.23
Next Earnings
May 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.16%
Share Statistics
EPS (TTM)1.60
Shares Outstanding158,273,650
10 Day Avg. Volume28,644
30 Day Avg. Volume16,535
Financial Highlights & Ratios
PEG Ratio1.06
Price to Book (P/B)5.05
Price to Sales (P/S)4.51
P/FCF Ratio80.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.55
Revenue Forecast (FY)₹10.60B
Bulls Say, Bears Say
Bulls Say
Revenue & Profitability GrowthSustained 68% five-year revenue growth and net margin expansion to 9% indicate durable demand and improving operating leverage. Persistent top-line expansion plus rising margins support continued cash generation and reinvestment capacity over the next 2–6 months and beyond.
Strong Balance Sheet & Improving LeverageA 62% equity ratio and falling debt-to-equity (0.35) provide financial flexibility to fund expansion or weather shocks. Lower leverage reduces refinancing and interest risks, enabling durable capital allocation decisions and strategic investments over the medium term.
Robust Cash Generation & FCF GrowthStrong operating cash conversion (OCF/net income 1.76) and 44% FCF growth demonstrate the business converts earnings into cash reliably. This underpins debt reduction, capex funding, and shareholder returns and supports financial resilience in coming quarters.
Bears Say
EBITDA Margins Lag PeersDespite profit improvement, EBITDA margins remain below industry leaders, indicating weaker operating efficiency or pricing power. Persistent margin gap could limit competitive flexibility and long-term return potential unless operational scale or mix improvements are achieved.
Fluctuating Net Debt LevelsReported swings in net debt introduce refinancing and liquidity uncertainty. Even with improving leverage metrics, variability in net debt can stress cash planning and raise funding costs during adverse conditions, reducing long-run predictability of financial commitments.
Suboptimal Free Cash Flow ConversionFCF/net income of ~0.63 suggests a meaningful share of earnings is tied up in working capital or capex. Lower conversion constrains discretionary spending and increases sensitivity to revenue shocks, making durable investment or payout policies harder to sustain.
Artemis Medicare Services Ltd. News
ARTEMISMED FAQ
What was Artemis Medicare Services Ltd.’s price range in the past 12 months?
Artemis Medicare Services Ltd. lowest stock price was ₹208.75 and its highest was ₹305.95 in the past 12 months.
What is Artemis Medicare Services Ltd.’s market cap?
Artemis Medicare Services Ltd.’s market cap is ₹37.68B.
When is Artemis Medicare Services Ltd.’s upcoming earnings report date?
Artemis Medicare Services Ltd.’s upcoming earnings report date is May 30, 2026 which is in 89 days.
How were Artemis Medicare Services Ltd.’s earnings last quarter?
Artemis Medicare Services Ltd. released its earnings results on Feb 02, 2026. The company reported ₹1.603 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.603.
Is Artemis Medicare Services Ltd. overvalued?
According to Wall Street analysts Artemis Medicare Services Ltd.’s price is currently Overvalued.
Does Artemis Medicare Services Ltd. pay dividends?
Artemis Medicare Services Ltd. pays a Annually dividend of ₹0.45 which represents an annual dividend yield of 0.16%. See more information on Artemis Medicare Services Ltd. dividends here
What is Artemis Medicare Services Ltd.’s EPS estimate?
Artemis Medicare Services Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Artemis Medicare Services Ltd. have?
Artemis Medicare Services Ltd. has 158,273,650 shares outstanding.
What happened to Artemis Medicare Services Ltd.’s price movement after its last earnings report?
Artemis Medicare Services Ltd. reported an EPS of ₹1.603 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.214%.
Which hedge fund is a major shareholder of Artemis Medicare Services Ltd.?
Currently, no hedge funds are holding shares in IN:ARTEMISMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Artemis Medicare Services Ltd.
Artemis Medicare Services Limited manages and operates multi specialty hospitals in India and internationally. The company offers medical and surgical intervention; and inpatient and outpatient services. It also operates Artemis Hospital, a 541 bed multi-specialty hospital located in Gurugram, India. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.
Technical Analysis
Fortis Healthcare Ltd.
―
Indraprastha Medical Corporation Limited
―
Krishna Institute of Medical Sciences Limited
―
Metropolis Healthcare Ltd.
―
Shalby Ltd.
―